A John Camm

A John Camm

Professor of Clinical Cardiology

PhD

St George’s University of London, London, UK

  • LinkedIn
  • X
  • Radcliffe
  • OrcidID

Biography

John Camm is British Heart Foundation Professor of Clinical Cardiology (Emeritus) at St George’s University of London, London, UK. His interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, and anticoagulation.

Prof Camm is Editor of the European Society of Cardiology Textbook of Cardiovascular Medicine and ESC CardioMed, Electrophysiology of the Heart, Clinical Cardiology and Evidence Based Cardiology.  He has written or edited more than 40 books, predominantly in the field of cardiac arrhythmology. He has authored or co-authored more than 1450 peer reviewed papers, more than 500 book chapters, and in excess of 2500 accepted abstracts.  He has delivered more than 1000 international lectures.

Prof Camm has been involved in the production of numerous guidelines, including the ESC guidelines for the management of atrial fibrillation.

Prof Camm is a member of the Arrhythmia & Electrophysiology Review editorial board.

Read more

Media

Claudio Tondo, A John Camm, Yuri Blaauw, et al

Watch time: 45m 1s (5 videos)

A John Camm, Martin Bergmann, Tim Betts, et al

A John Camm, Hugh Calkins, Claudio Tondo, et al

Watch time: 30m 2s

David Hildick-Smith, Tim Betts, A John Camm, et al

Watch time: 1h 32m 45s

Richard Schilling, KR Julian Chun, Isabel Deisenhofer, et al

Jens Erik Nielsen Kudsk, A John Camm, Vivek Reddy, et al

Watch time: 51m 8s

A John Camm, Paulus Kirchhof, Raffaele De Caterina, et al

NOAC

A John Camm, Paulus Kirchhof, Freek WA Verheugt, et al

Watch time: 15m 39s
NOAC

Freek WA Verheugt, A John Camm, Paulus Kirchhof, et al

Watch time: 19m 54s
NOAC

A John Camm, Raffaele De Caterina, Paulus Kirchhof, et al

Watch time: 17m 57s
NOAC

Paulus Kirchhof, A John Camm, Marco Alings, et al

Watch time: 20m 2s

A John Camm, Marco Alings, Raffaele De Caterina, et al

Articles by A John Camm, Professor of Clinical Cardiology

Novel Oral Anticoagulants (NOACs) Roundtable: Hot Topics and Current Issues in association with Arrhythmia & Electrophysiology Review

Katrina Mountfort, Paulus Kirchhof, A John Camm, et al

Citation: Arrhythmia & Electrophysiology Review, 2015;4(1)

Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy

C Fielder Camm, A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2017;6(2):63–8.

DOI:

https://doi.org/10.15420/aer.2017:4:2
Letter from the New President of the European Heart Rhythm Association

A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2017;6(3):107.

DOI:

https://doi.org/10.15420/aer.2017.31.GE2
A Clinical Perspective on Sudden Cardiac Death

Demosthenes G Katritsis, Bernard J Gersh, A John Camm, et al

Citation: Arrhythmia & Electrophysiology Review 2016;5(3):177–82

DOI:

https://doi.org/10.15420/aer.2016:11:2
Anticoagulation in Atrial Fibrillation – Current Concepts

Demosthenes G Katritsis, Bernard J Gersh, A John Camm, et al

Citation: Arrhythmia & Electrophysiology Review 2015;4(2):100–7

DOI:

https://doi.org/10.15420/aer.2015.04.02.100
Early Repolarisation Syndrome – New Concepts

Demosthenes G Katritsis, Bernard J Gersh, A John Camm, et al

Citation: Arrhythmia & Electrophysiology Review 2015;4(3):169–71

DOI:

https://doi.org/10.15420/aer.2015.4.3.169
Inherited Arrhythmias – Where do we Stand?

A John Camm, Bernard J Gersh, Demosthenes G Katritsis, et al

Citation: Arrhythmia & Electrophysiology Review 2014;3(2):80–4

DOI:

https://doi.org/10.15420/aer.2014.3.2.80
Stroke Prevention in Atrial Fibrillation – Outcomes and Future Directions

Katrina Mountfort, A John Camm, Gregory YH Lip, et al

Citation: Arrhythmia & Electrophysiology Review 2014;3(3):194–200

DOI:

https://doi.org/10.15420/aer.2014.3.3.194
The Role of Continuous Monitoring in Atrial Fibrillation Management

A John Camm,

Citation: Arrhythmia & Electrophysiology Review 2014;3(1):48-50

DOI:

https://doi.org/10.15420/aer.2011.3.1.48
Stroke Prevention in Atrial Fibrillation - The Unmet Need and Morbidity Burden

A John Camm,

Citation: European Cardiology 2011;7(3):187–95

DOI:

https://doi.org/10.15420/ecr.2011.7.3.187
Considerations for the Development of New Antiarrhythmic Drugs

A John Camm, Craig Pratt, Silvia Priori, et al

Citation: European Cardiology 2010;6(2 Suppl):3–7

DOI:

https://doi.org/10.15420/ecr.2010.6.2suppl.3
Epidemiology and Economic Burden of Atrial Fibrillation

A Bajpai, A John Camm, I Savelieva, et al

Citation: US Cardiology 2007;4(1):14–7

DOI:

https://doi.org/10.15420/usc.2007.4.1.14
Antidotes or Reversibility Agents – Are they Needed?

A John Camm,

Published:

Citation: Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):6-7

DOI:

https://doi.org/10.15420/aer.2015.4.1.S1
Once or Twice-daily NOAC Therapy – Theory and Practice

A John Camm,

Published:

Citation: Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):5

DOI:

https://doi.org/10.15420/aer.2015.4.1.S1

Keywords

cardiac arrhythmia, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac electrophysiology, cardiac pacemakers, myocardial infarction, heart failure, cardiomyopathy